Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Electrocardiography × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 2 Carcinoma in Situ 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Lymphoma 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Breast Neoplasms 1 Bone Marrow Diseases 1 Anus Neoplasms 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡